RCM
ONC

RA Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

RA Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-240,000
Closed -$8.79M – 25
2017
Q1 		$8.79M Hold
240,000
– – 1.08% 17
2016
Q4 		$7.29M Buy
240,000
+70,000
+41% +$2.2M 1.03% 15
2016
Q3 		$5.24M Hold
170,000
– – 0.54% 24
2016
Q2 		$5.07M Hold
170,000
– – 0.7% 25
2016
Q1 		$4.98M Buy
+170,000
New +$4.82M 0.64% 30

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

RA Capital Management's ONC Position: Q2 2017 in Review

RA Capital Management sold out of BeOne Medicines Ltd (ONC) in Q2 2017, closing a stake of 240,000 shares — an estimated $8.79M sold.

RA Capital Management first reported a position in ONC in Q1 2016 and held it in 5 quarters. The position peaked at $8.79M in Q1 2017. 57 funds tracked by Wall St. Rank hold ONC as of Q2 2017.

  • RA Capital Management reported no remaining BeOne Medicines Ltd position as of Q2 2017 after selling out during the quarter.
  • RA Capital Management sold 240,000 BeOne Medicines Ltd shares in Q2 2017, an estimated $8.79M.
  • RA Capital Management first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 5 quarters.
  • RA Capital Management's BeOne Medicines Ltd position peaked at $8.79M in Q1 2017.
  • 57 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2017.

Based on RA Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.